The effects of captopril on cardiac regression, blood pressure and bradykinin components in diabetic Wistar Kyoto rats

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue 2, 2011, Pages 337-343

  Sharma, J N ^a   Kesavarao, U ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b SCHOOL OF PHYSICS   (Malaysia)

Author keywords

Blood pressure; Captopril; Cardiac wall thickness; Diabetes; Kallikrein; Kininogen; WKY rats

Indexed keywords

BRADYKININ; CAPTOPRIL; KALLIKREIN; KININOGEN; PLASMA KALLIKREIN; TISSUE KALLIKREIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC HYPERTENSION; DISEASE COURSE; DRUG EFFECT; HEART VENTRICLE HYPERTROPHY; KALLIKREIN URINE LEVEL; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RAT; DRUG EFFICACY; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HYPERTENSION; PROTEIN BLOOD LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; URINALYSIS; WISTAR KYOTO RAT; ANIMAL; BLOOD; BLOOD PRESSURE; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HEART VENTRICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TIME; URINE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE; BRADYKININ; CAPTOPRIL; DIABETES COMPLICATIONS; DIABETES MELLITUS, EXPERIMENTAL; HEART VENTRICLES; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; KALLIKREINS; KININOGENS; MALE; RATS; RATS, INBRED WKY; TIME FACTORS;

EID: 80051735865     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201102400207     Document Type: Article

References (29)

1. Leeb-Lundberg LMF, Marceau F, Muller-Esterl W, Pettibone DJ, Zuraw BL. International Union of Pharmacology. XLV. Classification of the kinin receptor family: From molecular mechanisms to pathophysiological consequences. Pharmacol Rev 2005; 57:27-77. (Pubitemid 40283969)
2. Katori M, Majima M. A missing link between a high salt intake and blood pressure increase. J Pharmacol Sci 2006; 100:370-90. (Pubitemid 44609529)
3. Linz W, Wiemer G, Scholkens BA. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy. Braz J Med Biol Res 1994; 8:1949-54. (Pubitemid 24274435)
4. Sharma JN. Activation of the bradykinin system by angiotensin converting enzyme inhibitors. Eur J Inflammation 2010; 8:55-61.
5. Sharma JN, Uma K. Cardiac kallikrein in hypertensive and normotensive rats with and without diabetes. Immunopharmacol 1996; 33:341-43. (Pubitemid 26247964)
6. Wang C, Chao L, Chao J. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension 1994; 23:236-43. (Pubitemid 24050287)
7. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19:403-18.
8. Liu YJ, Nakagawa Y, Toya K, Wang Y, Saegusa H, Nakanishi T, Ohzeki T. Effects of spironolactone on systolic blood pressure in experimental diabetic rats. Kidney International 2000; 57:2064-71. (Pubitemid 30252298)
9. Hayashi M, Nagasaka T. Suppression of norepinephrine-induced thermogenesis in brown adipose tissue by fasting. Am J Physiol 1983; 245:E582-6. (Pubitemid 14216802)
10. Anversa P, Olivetti G, Melisaari M, Loud AV. Morphometric study of myocardial hypertrophy induced by abdominal aortic stenosis. Lab Invest 1979; 40:341-8.
11. Sharma JN, Kesavarao U. Effect of captopril on urinary kallikrein, blood pressure and myocardial hypertrophy in diabetic spontaneously hypertensive rats. Pharmacology 2002; 64:196-200. (Pubitemid 34225015)
12. Sharma JN, Uma K, Yusof AP. Altered cardiac tissue and plasma kininogen levels in hypertensive and diabetic rats. Immunopharmacol 1999; 43:129-32.
13. Kawashima H, Igarashi T, Nakajima Y, Akiyama Y, Usuki K, Ohtake S. Chronic hypertension induced by streptozotocin in rats. Arch Pharmacol 1979; 305:123-26.
14. Pellufo V, Costa MA, Prendes MGM, Catanzam OL. Renal alteration and development of hypertension in diabetic rats. Agents actions 1992; 38(S):50-57.
15. Somani P, Singh HP, Saini PK, Rabinovich A. Streptozotocin induced diabetes in the spontaneously hypertensive rats. Metabolism 1979; 28:1075-77. (Pubitemid 10191948)
16. Silberbauer K, Stanek B, Temple H. Acute hypotensive effect of captopril in man modified by prostaglandin synthesis inhibition. Br J Clin Pharmacol 1982; 14:87S-93S. (Pubitemid 13141824)
17. Sharma JN, Fernandez PG, Kim BK. Cardiac regression and blood pressure control in Dah1 rats treated with enalapril maleate (MK 421), an angiotensin converting enzyme inhibitor. J Hypertension 1983; 1:251-6. (Pubitemid 14161949)
18. Sharma JN, Stewart JM, Mohsin SJ, Katori M, Vavrek R. Influence of a kinin antagonist on acute hypotension responses induced by bradykinin and captopril in spontaneously hypertensive rats. Agents Actions 1992; 38(S):258-69.
19. Trippodo NC, Frohlich ED. The genetically hypertensive rat as a model of human essential hypertension. Circ Res 1981; 48:309-19.
20. Sharma JN, Uma K, Yusof APM. Left ventricular hypertrophy and its relation to cardiac kinin-forming system in hypertensive and diabetic rats. Int J Cardiol 1998; 63:229-35. (Pubitemid 28150000)
21. Linz W, Wiemer G, Scholkens BA. Bradykinin prevents left ventricular hypertrophy in rats. J Hypertens 1993; 11(S):96-97.
22. Ader JL, Pollack DM, Butterfield MI, Arendshort WJ. Abnormalities in kallikrein excretion in spontaneously hypertensive rats. Am J Physiol 1985; 248:F396-F403. (Pubitemid 15142310)
23. Margolius HS, Geller R, DeJong W. Altered urinary kallikrein excretion in rats hypertension. Cir Res 1972; 30:358-62.
24. Majima M, Katori M, Hanazuka M, et al. Suppression of rat deoxycorticosterone-salt hypertension by kallikrein-kinin system. Hypertension 1991; 17:806-13.
25. Chao J, Chao L. Kallikrein gene therapy in hypertension, cardiovascular and renal diseases. Gen Ther Mol Biol 1998; 1:301-8.
26. Overlack A, Stumpe KO, Kollock R, Ressel C, Krueck F. Antihypertensive effect of orally administered glandular kallikrein in essential hypertension. Hypertension 1981; 3:118-21.
27. Sen S, Tarazi RC, Bumpus FM. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res 1977; 11:427-33. (Pubitemid 8198638)
28. Dahlof B, Pennert K, Hanson L. Reversal of left ventricular hypertrophy in hypertensive patients: A meta analysis of 109 treated studies. Am J Hypertension 1992; 5:95-110.
29. Sharma JN, Kesavarao U. Changes in plasma prekallikrein activity, blood pressure and left ventricular thickness in hypertensive and normotensive diabetic rats. Methods Find Exp Clin Pharmacol 2007; 29:75-8. (Pubitemid 46797625)